Annapolis Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,078
| Closed | -$96.3K | – | 472 |
|
2023
Q4 | $96.3K | Hold |
1,078
| – | – | 0.02% | 151 |
|
2023
Q3 | $78.7K | Hold |
1,078
| – | – | 0.02% | 160 |
|
2023
Q2 | $89.7K | Hold |
1,078
| – | – | 0.03% | 151 |
|
2023
Q1 | $82.2K | Hold |
1,078
| – | – | 0.02% | 147 |
|
2022
Q4 | $89.5K | Sell |
1,078
-313
| -23% | -$26K | 0.03% | 143 |
|
2022
Q3 | $110K | Sell |
1,391
-330
| -19% | -$26.1K | 0.04% | 135 |
|
2022
Q2 | $128K | Sell |
1,721
-605
| -26% | -$45K | 0.05% | 128 |
|
2022
Q1 | $209K | Sell |
2,326
-1,149
| -33% | -$103K | 0.07% | 106 |
|
2021
Q4 | $389K | Hold |
3,475
| – | – | 0.12% | 88 |
|
2021
Q3 | $437K | Hold |
3,475
| – | – | 0.15% | 82 |
|
2021
Q2 | $471K | Hold |
3,475
| – | – | 0.16% | 76 |
|
2021
Q1 | $471K | Hold |
3,475
| – | – | 0.17% | 66 |
|
2020
Q4 | $489K | Buy |
+3,475
| New | +$489K | 0.19% | 63 |
|